Every night on "Mad Money," Jim Cramer offers market commentary and general investment advice, and he makes calls on specific stocks, both of his own choosing and in response to viewer requests. He relies on his many years of experience and strong track record, and he takes full responsibility for his calls.

" I never shirk from admitting my mistakes; instead, I dwell on them to learn from them. I change my mind, I take losses, I own up to them," Cramer has said.

Here we track some of his calls from the previous episode of "Mad Money" and find out, at least in the very short term, how the stocks are performing. Keep in mind that Cramer might not have been recommending that viewers take immediate action on a stock. And, of course, it's up to the individual investor to do his or her own homework.

That said, here's how some of the stocks that Cramer talked about on Tuesday's "Mad Money" show fared today.

Charming Shoppes ( CHRS): Charming Shoppes was Cramer's speculative retail play on Tuesday's show. He said that lower gas prices correspond to higher sales at the retailer. He liked the company's improving fundamentals and said it could be a takeover target. On Wednesday, Charming Shoppes rose 17 cents, or 4.8%, to close at $3.72.

McCormick ( MKC): Cramer didn't find much to smile about in spice maker McCormick's most recent quarter, and he worried about competition from Wal-Mart ( WMT). He prefered defensive plays such as Kraft ( KFT) and Action Alerts PLUS name General Mills ( GIS).

On Wednesday, McCormick added 18 cents, or 0.6%, to $32.77, while Kraft slipped 5 cents to $25.70, and General Mills fell 56 cents, or 0.9%, to $58.86.

Research In Motion ( RIMM): In his "Lightning Round" segment, Cramer said that RIM had "too much competition" and wasn't done going down. On Wednesday, the stock closed down 74 cents, or 1.1%, at $65.62.

ConocoPhillips ( COP): Conoco is too leveraged to the free-falling natural gas, said Cramer. On Wednesday, it lost 55 cents, or 1.4%, to close at $39.44.

Dendreon ( DNDN): Cramer said Dendreon's "new drug is for real" and approved of the stock as a speculative pick. On Wednesday, Dendreon closed down $1.30, or 5.4%, at $22.72.

(Editor's note: At the time of publication, Cramer owned General Mills for his Action Alerts PLUS charitable trust.)